- Home
- Publications
- Publication Search
- Publication Details
Title
New treatment options for delta virus: Is a cure in sight?
Authors
Keywords
-
Journal
JOURNAL OF VIRAL HEPATITIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-02-17
DOI
10.1111/jvh.13081
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biological basis for functional cure of chronic hepatitis B
- (2019) Maria G. Martinez et al. JOURNAL OF VIRAL HEPATITIS
- Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study
- (2018) Cihan Yurdaydin et al. HEPATOLOGY
- Subanalysis of the LOWR HDV-2 study reveals high response rates to Lonafarnib in patients with low viral loads
- (2018) C. Yurdaydin et al. JOURNAL OF HEPATOLOGY
- Establishment of persistent functional remission of HBV and HDV infection following REP 2139 and pegylated interferon alpha 2a therapy in patients with chronic HBV/HDV co-infection: 18 month follow-up results from the REP 301-LTF study
- (2018) M. Bazinet et al. JOURNAL OF HEPATOLOGY
- Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B
- (2018) Harry L.A. Janssen et al. JOURNAL OF HEPATOLOGY
- Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection
- (2018) H. Wedemeyer et al. JOURNAL OF HEPATOLOGY
- Interferon Treatment Duration in Patients With Chronic Delta Hepatitis and its Effect on the Natural Course of the Disease
- (2018) Cihan Yurdaydin et al. JOURNAL OF INFECTIOUS DISEASES
- REP 2139: antiviral mechanisms and applications in achieving functional control of HBV and HDV infection
- (2018) Andrew Vaillant ACS Infectious Diseases
- A phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis – end of study results from the LOWR HDV-3 study
- (2017) C. Koh et al. JOURNAL OF HEPATOLOGY
- Hepatitis delta-associated mortality in HIV/HBV-coinfected patients
- (2017) Charles Béguelin et al. JOURNAL OF HEPATOLOGY
- A phase 2 dose-escalation study of lonafarnib plus ritonavir in patients with chronic hepatitis D: final results from the Lonafarnib with ritonavir in HDV-4 (LOWR HDV-4) study
- (2017) H. Wedemeyer et al. JOURNAL OF HEPATOLOGY
- A phase1 study evaluating anti-PD-1 treatment with or without GS-4774 in HBeAg negative chronic hepatitis B patients
- (2017) E. Gane et al. JOURNAL OF HEPATOLOGY
- Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice
- (2017) Katja Giersch et al. Scientific Reports
- The hepatitis D satellite virus of hepatitis B virus
- (2016) Natali Abeywickrama-Samarakoon et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Antiviral treatment and liver-related complications in hepatitis delta
- (2016) Anika Wranke et al. HEPATOLOGY
- Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)
- (2016) Henry L.Y. Chan et al. JOURNAL OF HEPATOLOGY
- First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
- (2016) Antje Blank et al. JOURNAL OF HEPATOLOGY
- Aiming for cure in HBV and HDV infection
- (2016) Jörg Petersen et al. JOURNAL OF HEPATOLOGY
- Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
- (2016) Pavel Bogomolov et al. JOURNAL OF HEPATOLOGY
- Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options
- (2016) Florian A. Lempp et al. Nature Reviews Gastroenterology & Hepatology
- Comparison of the efficacy of 12 months and longer courses of interferon therapy for the treatment of chronic delta hepatitis: a retrospective cohort study
- (2016) Ozlem Mutluay Soyer et al. POSTGRADUATE MEDICINE
- Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection
- (2016) Mamun Al-Mahtab et al. PLoS One
- Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome
- (2015) Onur Keskin et al. Clinical Gastroenterology and Hepatology
- The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
- (2015) Edward J. Gane et al. JOURNAL OF HEPATOLOGY
- Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
- (2015) Christopher Koh et al. LANCET INFECTIOUS DISEASES
- Therapy of Delta Hepatitis
- (2015) Cihan Yurdaydin et al. Cold Spring Harbor Perspectives in Medicine
- Hepatitis Delta Is a Major Determinant of Liver Decompensation Events and Death in HIV-Infected Patients
- (2014) J. V. Fernandez-Montero et al. CLINICAL INFECTIOUS DISEASES
- Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta
- (2014) Benjamin Heidrich et al. HEPATOLOGY
- Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modeling
- (2014) Jeremie Guedj et al. HEPATOLOGY
- A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
- (2014) Andrew J. Muir et al. JOURNAL OF HEPATOLOGY
- Effect of Tenofovir With and Without Interferon on Hepatitis D Virus Replication in HIV–Hepatitis B Virus–Hepatitis D Virus-Infected Patients
- (2013) Anders Boyd et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Nucleic Acid Polymers Prevent the Establishment of Duck Hepatitis B Virus InfectionIn Vivo
- (2013) Faseeha Noordeen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nucleic Acid Polymers Inhibit Duck Hepatitis B Virus InfectionIn Vitro
- (2013) Faseeha Noordeen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prevalence and clinical course of hepatitis delta infection in Greece: A 13-year prospective study
- (2013) Emanuel K. Manesis et al. JOURNAL OF HEPATOLOGY
- Entecavir Treatment of Chronic Hepatitis D
- (2012) G. Kabacam et al. CLINICAL INFECTIOUS DISEASES
- A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus A-determinant
- (2012) Camille Sureau et al. HEPATOLOGY
- Treatment of Chronic Delta Hepatitis
- (2012) Cihan Yurdaydin SEMINARS IN LIVER DISEASE
- Improved Immune Status Corresponds with Long-Term Decline of Quantitative Serum Hepatitis B Surface Antigen in HBV/HIV Co-infected Patients
- (2012) Eduard Arendt et al. VIRAL IMMUNOLOGY
- Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
- (2012) Huan Yan et al. eLife
- IFN-λs
- (2011) Sergei V Kotenko CURRENT OPINION IN IMMUNOLOGY
- Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
- (2011) Heiner Wedemeyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interferon Impedes an Early Step of Hepatitis Delta Virus Infection
- (2011) Ziying Han et al. PLoS One
- Natural history and treatment of chronic delta hepatitis
- (2010) C. Yurdaydın et al. JOURNAL OF VIRAL HEPATITIS
- Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study
- (2010) M. Buti et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis delta virus inhibits alpha interferon signaling
- (2008) Paolo Pugnale et al. HEPATOLOGY
- Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon
- (2008) C. Yurdaydın et al. JOURNAL OF VIRAL HEPATITIS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started